KR20190014435A - Method for producing buckwheat sprout with increased rutin contents - Google Patents
Method for producing buckwheat sprout with increased rutin contents Download PDFInfo
- Publication number
- KR20190014435A KR20190014435A KR1020170098288A KR20170098288A KR20190014435A KR 20190014435 A KR20190014435 A KR 20190014435A KR 1020170098288 A KR1020170098288 A KR 1020170098288A KR 20170098288 A KR20170098288 A KR 20170098288A KR 20190014435 A KR20190014435 A KR 20190014435A
- Authority
- KR
- South Korea
- Prior art keywords
- buckwheat
- extract
- germinated
- ethanol
- present
- Prior art date
Links
- 235000009419 Fagopyrum esculentum Nutrition 0.000 title claims abstract description 71
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 title claims abstract description 31
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 229960004555 rutoside Drugs 0.000 title claims abstract description 31
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 title claims abstract description 30
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 235000005493 rutin Nutrition 0.000 title claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 title claims abstract 10
- 241000219051 Fagopyrum Species 0.000 title claims 15
- 239000000284 extract Substances 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 15
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 10
- 230000002087 whitening effect Effects 0.000 claims abstract description 9
- 239000002537 cosmetic Substances 0.000 claims abstract description 8
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 240000008620 Fagopyrum esculentum Species 0.000 abstract description 56
- 230000035784 germination Effects 0.000 abstract description 17
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 24
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 22
- 210000003491 skin Anatomy 0.000 description 14
- 102000003425 Tyrosinase Human genes 0.000 description 11
- 108060008724 Tyrosinase Proteins 0.000 description 11
- -1 tracant Substances 0.000 description 11
- 244000130270 Fagopyrum tataricum Species 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 8
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000014693 Fagopyrum tataricum Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 3
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- FYUNQERIZAJDPT-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;ethanol Chemical compound CCO.OC(=O)C(O)C(O)C(O)=O FYUNQERIZAJDPT-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-UHFFFAOYSA-N 3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100032606 Heat shock factor protein 1 Human genes 0.000 description 1
- 101000867525 Homo sapiens Heat shock factor protein 1 Proteins 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 239000004159 Potassium persulphate Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- VVXVTYYCCQZUKK-UHFFFAOYSA-N quercetin 3-rutinoside Natural products CC1OC(OCC2OC(OC3=C(Oc4ccc(O)c(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O VVXVTYYCCQZUKK-UHFFFAOYSA-N 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000031019 skin pigmentation disease Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/152—Cereal germ products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
- A23V2250/2117—Rutin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 메밀의 루틴 함량을 향상시키는 방법에 관한 것으로, 구체적으로, 루틴 함량을 증가시키기 위한 특정 발아조건으로 발아된 루틴 함량이 증가된 발아 메밀과, 루틴 함량이 증진된 발아 메밀 에탄올 추출물의 제조방법 및 이의 기능성에 관한 것이다.More particularly, the present invention relates to a method for improving the rutin content of buckwheat, and more particularly, to a method for improving the rutin content of buckwheat, Methods and their functionality.
현대 여성들은 하얗고 깨끗한 피부를 선호하기 때문에 피부색소 이상 침착의 치료 및 미용욕구 충족을 위한 미 백에 대한 관심이 높아지고 있다. 피부는 외부 환경과 직접 접하면서 인체를 보호하며 생화학적이고 물리적인 기능을 가지는 아주 중요한 조직이다. 멜라닌은 피부의 표피층에 존재하는 색소로서, 표피의 기저층에 존재하는 멜라노사이트(melanocyte)로부터 만들어져 케라티노사이트(keratinocyte)라는 표피 세포로 이동한다. 생체 내에는 멜라닌을 분해하는 효소가 없고, 다만 케라티노사이트가 표피에서 떨어져 나갈 때 같이 피부에서 떨어져 나가는 것으로 제거된다. 멜라노사이트 내의 멜라노좀이라는 소포체에서 티로시나제(Tyrosinase) 효소에 의해 티로신이 도파(DOPA)를 거쳐 도파퀴논(DOPAquinone)으로 전환되고, 도파퀴논의 자동 산화반응과 효소반응으로 도파크롬(DOPAchrome)을 거쳐 흑갈색의 공중합체인 멜라닌이 생성된다. 이렇게 생성된 멜라닌은 멜라노좀을 통해 케라티노사이트로 옮겨지고 여기에서 약 28일간의 각화 과정을 거치면서 피부 표면으로 나와 각 질과 함께 소실된다. 멜라닌은 햇빛 UV의 빛 에너지를 흡수하여 UV에 의한 손상으로부터 진피 이하의 피부 기관을 보호하는 역할을 하며, 피부 생체 내에 생겨난 유해산소 및 프리라디칼 등을 잡아주는 등 외부 유해인자로부터 피부를 보호해주는 유용한 역할을 수행한다. 또한, 피부 세포 내의 멜라닌은 사람의 피부색을 결정한다. 멜라닌 색소가 많은 사람은 갈색 또는 검은색 피부를 갖는 반면, 멜라닌 색소가 적은 사람은 흰색의 피부를 갖게 된다. 현재 피부미용을 위한 미백 방법으로는 생성된 멜라닌 색소를 환원시켜 탈색하는 방법과 멜라닌 색소를 형성하는 효소인 티로시나제의 활성을 억제하는 방법이 알려져 있다. 멜라닌 색소를 환원시키기 위해 토코페롤이나 비타민류 등을 사용한 미백제는 멜라닌 색소의 탈색효과가 미미하므로, 티로시나제의 활성을 저해함으로써 멜라닌 색소의 생성을 억제하는 저해제가 주목받고 있다.Because modern women prefer white, clean skin, there is growing interest in the treatment of skin pigmentation disorders and the need for skin care to meet beauty needs. Skin is a very important tissue that protects the human body in direct contact with the external environment and has biochemical and physical functions. Melanin is a pigment present in the epidermis of the skin. It is made from melanocytes in the basal layer of the epidermis and migrates to epidermal cells called keratinocytes. In vivo, there is no enzymes that degrade melanin, but keratinocytes are removed from the skin as they fall off the epidermis. Tyrosine is converted to DOPAquinone via DOPA by the tyrosinase enzyme in the melanocytoin in the melanocyte site and is converted to DOPAquinone by the DopAchrome through the autoxidation reaction and the enzyme reaction of dopaquinone, Melanin is produced. The resulting melanin is transferred to the keratinocyte through the melanoma, and after about 28 days of keratinization, it exits the skin surface and disappears with the vagina. Melanin absorbs the light energy of sunlight UV and protects the subcutaneous skin organs from UV damage. It also helps protect the skin from external harmful factors such as harmful oxygen and free radicals generated in the skin. Role. In addition, melanin in skin cells determines the skin color of a person. People with high melanin pigment have brown or black skin while those with low melanin pigment have white skin. As a whitening method for skin cosmetics, there is known a method of decolorizing by reducing the produced melanin pigment and a method of inhibiting the activity of tyrosinase, an enzyme that forms a melanin pigment. The whitening agent using tocopherol, vitamins or the like for reducing the melanin pigment has a small discoloring effect of the melanin pigment, so that an inhibitor that inhibits the activity of the tyrosinase has been attracting attention.
한편, 메밀(buckwheat)은 마디풀과(Polygonaceae)에 속하는 쌍떡잎식물로서 일년초로 일반적으로 많이 알려진 메밀의 종류는 일반 메밀(common buckwheat, Fagopyrum esculentum Moench)과 쓴메밀(tartary buckwheat, Fagopyrum tataricum Gaertner)이라 불리는 타타리 메밀이 있다. 메밀에는 12 내지 15%의 단백질이 함유되어 있고, 특히 필수 아미노산이 많이 함유되어 있으며, 지방, 철, 인, 동, 아연 등의 무기질 및 비타민 B1, B2가 비교적 많이 함유되어 있을 뿐 아니라, 특히 근래에 의약 용도로 사용이 급증되고 있는 루틴의 함량이 매우 높은 것으로 알려져 있다. 이러한 루틴의 함량은 일반메밀보다는 타타리메밀에 많이 포함되어 있고, 이를 발아시키게 되면 더욱 높아지게 되나, 일반적인 발아에서는 루틴함량을 극적으로 높일 수는 없었다. 루틴(Rutin) (quercetin-3-rutinoside)은 자연계에서 널리 분포하고 있는 flavonoid계 물질로 다른 곡류보다 메밀에서의 함량이 높고, 메밀에서 최초로 분리되었기 때문에 메밀은 Rutin의 기원 식물이 된다. 루틴은 퀘르세틴(quercetin)에 루티노즈(rutinose) (rhamnose와 glucose가 결합된 이당류)가 결합된 것으로 황색에서 담황색을 띠고 있다. 일명 비타민 P로도 알려져 있는 루틴은 혈관의 저항성을 강하게 하여 뇌출혈을 예방하는 중요한 성분으로 보고되어 있을 뿐 아니라, 혈관계 질환의 치료제로서 혈관의 지나친 투과성을 억제하는 약리 효과도 가지고 있음이 공지되어 있다. 최근에는 당뇨 및 암에도 그 약효가 있는 것으로 나타나 그에 대한 연구가 더욱더 활발해 지고 있다.On the other hand, buckwheat is a dicotyledonous plant belonging to the family Polygonaceae. The buckwheat variety commonly known as perennial is called common buckwheat ( Fagopyrum esculentum Moench ) and tartary buckwheat ( Fagopyrum tataricum Gaertner) There is tatami buckwheat. The buckwheat contains 12 to 15% protein, especially contains a large amount of essential amino acids, and contains a relatively large amount of minerals such as fat, iron, phosphorus, copper, zinc and vitamins B1 and B2, Is known to have a very high content of routinely used drugs. The content of these routines was much higher in the tartar buckwheat than in the general buckwheat, but it was higher when germinated, but the routine content could not be dramatically increased in general germination. Rutin (quercetin-3-rutinoside) is a flavonoid substance which is widely distributed in nature. It has higher content in buckwheat than other grains, and buckwheat is the origin of Rutin because it was first separated from buckwheat. Rutin is a combination of quercetin with rutinose (disaccharide with rhamnose and glucose), which is yellow to light yellow. It is known that a routine known as vitamin P is an important ingredient for preventing the intracerebral hemorrhage by strengthening resistance of blood vessels and also has a pharmacological effect for inhibiting excessive permeability of blood vessels as a therapeutic agent for vascular diseases. Recently, it has been shown that diabetes and cancer are also effective, and research on it has become more active.
이에, 루틴 함량을 향상시킨 발아 메밀을 제조하기 위해 본 발명자들은 발아과정에서 발아 조건인 수분, 빛, 산소를 변화시켜 루틴 함량을 극적으로 높일 수 있는 최적 발아 조건을 도출함으로써, 기능성 물질이 다량 함유된 메밀싹을 농산물고부가가치 작물로 이용하고, 이로부터 루틴을 추출하여 식품 및 기능성 식품의 소재로서의 활용하고자 하였다.In order to produce germinated buckwheat with improved rutin content, the present inventors have found that optimum germination conditions capable of dramatically increasing the content of rutin by changing moisture, light, and oxygen, which are germination conditions, Buckwheat sprouts were used as agricultural high value crops and extracted from them to utilize them as food and functional foods.
본 발명에서는 루틴 함량이 증가된 발아 메밀을 제조하는 방법을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a method for producing germinated buckwheat with increased rutin content.
또한, 본 발명에서는 루틴 함량이 증가된 메밀싹을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a buckwheat sprout having an increased rutin content.
또한, 본 발명에서는 루틴 함량이 증가된 메밀싹 에탄올 추출물을 제조하는 방법을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a method for producing an ethanol extract of buckwheat sprouts with increased rutin content.
아울러, 본 발명에서는 메밀싹 에탄올 추출물을 유효성분으로 포함하는 항산화 및 미백 조성물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide an antioxidative and whitening composition containing an extract of buckwheat ethanol as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명자들은 메밀의 루틴 함량을 최대화하기 위하여, 타타리 메밀의 최적 발아 조건을 도출하였으며, 제조된 발아 메밀싹의 추출물에 루틴 함량이 현저히 함유된 추출 조건을 도출하였고, 상기 추출물의 기능성을 확인하였다.In order to achieve the above object, the inventors of the present invention derive optimal germination conditions of tartar buckwheat to maximize the rutin content of buckwheat, and have extracted extraction conditions containing the rutin content significantly in the extract of germinated buckwheat sprouts, The functionality of the extract was confirmed.
본 발명의 발아 메밀 제조방법은 발아된 메밀의 루틴 함량을 현저하게 증진시키며, 상기 방법으로 제조된 발아된 메밀싹을 특정 조건으로 추출한 추출물에서 루틴 함량이 현저하게 증가하였으므로, 이를 고부가가치 농산물로 이용할 수 있고, 상기 추출물은 우수한 항산화 및 미백 활성을 가지므로, 이를 기능성 화장품 또는 기능성 식품 소재로서 활용할 수 있다. The germinated buckwheat production method of the present invention remarkably improves the germinated buckwheat rutin content, and the germinated buckwheat sprouts produced by the above method have been remarkably increased in the extracts obtained by extracting the germinated buckwheat seeds under specific conditions. Therefore, the germinated buckwheat can be used as a high value added agricultural product Since the extract has excellent antioxidative and whitening activity, it can be utilized as a functional cosmetic or a functional food material.
도 1은 메밀의 발아 과정을 도식화한 도이다.
도 2는 발아 조건에 따른 메밀싹 열수 또는 에탄올 추출물의 루틴 함량을 확인한 도이다.
도 3은 발아 조건에 따른 메밀싹 열수 또는 에탄올 추출물의 항산화 활성을 확인한 도이다.
도 4는 발아 조건에 따른 메밀싹 열수 또는 에탄올 추출물의 티로시나제 저해 활성을 확인한 도이다.Fig. 1 is a diagram illustrating the germination process of buckwheat.
FIG. 2 is a graph showing the content of rutin in the extract of buckwheat sprout or ethanol according to the germination condition.
FIG. 3 shows antioxidant activity of the extract of buckwheat hot water or ethanol according to germination conditions.
FIG. 4 is a view showing tyrosinase-inhibiting activity of the extract of buckwheat hot water or ethanol according to the germination condition.
이하, 본 발명의 구현예로 본 발명을 상세히 설명하기로 한다. 다만, 하기 구현예는 본 발명에 대한 예시로 제시되는 것으로, 이에 의해 본 발명이 제한되지는 않으며 본 발명은 후술하는 특허청구범위의 기재 및 그로부터 해석되는 균등 범주 내에서 다양한 변형 및 응용이 가능하다. Hereinafter, the present invention will be described in detail with reference to embodiments of the present invention. It should be understood, however, that the invention is not limited thereto and that various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined by the appended claims and their equivalents. .
일 측면에서, 본 발명은 메밀을 물에 침지하는 단계; 18 내지 22℃의 암조건하에서 20 내지 30시간 동안 생육하는 단계; 및 14,000Lux 이상의 광조건하에서 8일 동안 생육하여 메밀을 발아시키는 단계를 포함하는, 루틴 함량이 증가된 발아 메밀을 제조하는 방법에 관한 것이다.In one aspect, the present invention provides a method of making buckwheat, comprising: dipping buckwheat in water; Growing under the dark condition at 18 to 22 캜 for 20 to 30 hours; And germinating the buckwheat for 8 days under the light condition of 14,000 Lux or more, to produce germinated buckwheat with increased rutin content.
일 구현예에서, 상기 광조건은 LED일 수 있다.In one embodiment, the light condition may be an LED.
일 구현예에서, 상기 메밀은 타타리 메밀(Tartary Buckwheat)일 수 있다.In one embodiment, the buckwheat may be a Tartary Buckwheat.
일 측면에서, 본 발명은 본 발명의 방법으로 제조된 루틴 함량이 증가된 메밀싹에 관한 것이다.In one aspect, the invention relates to buckwheat sprouts having increased rutin content prepared by the method of the present invention.
일 측면에서, 본 발명은 메밀을 물에 침지하는 단계; 18 내지 22℃의 암조건하에서 20 내지 30시간 동안 생육하는 단계; 14,000Lux 이상의 광조건하에서 8일 동안 생육하여 메밀을 발아시키는 단계; 발아된 메밀을 건조 및 분말화하는 단계; 및 발아 메밀 분말을 에탄올로 추출하는 단계를 포함하는, 루틴 함량이 증가된 메밀싹 에탄올 추출물을 제조하는 방법에 관한 것이다.In one aspect, the present invention provides a method of making buckwheat, comprising: dipping buckwheat in water; Growing under the dark condition at 18 to 22 캜 for 20 to 30 hours; Growing the buckwheat by growing for 8 days under a light condition of 14,000 Lux or more; Drying and pulverizing the germinated buckwheat; And extracting the germinated buckwheat powder with ethanol. The present invention also relates to a method for producing an ethanol extract of buckwheat sprouts having an increased rutin content.
일 구현예에서, 에탄올로 추출한 뒤 초음파 추출하는 단계를 추가로 포함할 수 있다.In one embodiment, extraction with ethanol followed by sonication may be further included.
일 구현예에서, 메밀 발아 조건은 17 내지 20℃, 상대습도 80 내지 100%일 수 있다.In one embodiment, the buckwheat germination conditions may be 17-20 < 0 > C, relative humidity 80-100%.
본 발명에서 사용된 용어 "추출물(extract)"이란 천연물로부터 분리된 활성성분 즉, 목적하는 활성을 보이는 물질을 의미한다. 상기 추출물은 물, 유기용매 또는 이들의 혼합용매를 이용하는 추출과정으로 획득할수 있으며, 추출물의 건조 분말 또는 이를 이용하여 제형화된 모든 형태를 포함한다. 또한, 상기 추출물에는 상기 추출과정을 거친 추출물을 분획한 것도 포함된다.As used herein, the term "extract" means an active ingredient isolated from a natural product, i.e., a substance exhibiting the desired activity. The extract can be obtained by an extraction process using water, an organic solvent, or a mixed solvent thereof, and includes all the forms that are formulated using the dry powder of the extract. In addition, the above-mentioned extract also includes fractions obtained by fractionating the extract obtained through the above extraction process.
본 발명의 메밀싹 추출물의 추출 용매로는 물, C1-C4의 저급 알코올과 같은 극성 용매나 헥산, 클로로 포름, 디클로로메탄 또는 에틸아세테이트와 같은 비극성 용매, 또는 이들 중 2 이상의 혼합물을 사용할 수도 있으나, 에탄올 추출물의 루틴 함량이 현저하므로 에탄올로 추출한 에탄올 추출물이 가장 바람직하다. The extraction solvent of the extract of buckwheat sprouts of the present invention may be a polar solvent such as water, a C 1 -C 4 lower alcohol, a nonpolar solvent such as hexane, chloroform, dichloromethane or ethyl acetate, or a mixture of two or more thereof However, since the ethanol content of the ethanol extract is remarkable, the ethanol extract extracted with ethanol is most preferable.
일 구현예에서, 본 발명의 방법으로 제조된 메밀싹 에탄올 추출물의 루틴 함량은 1000ppm 이상일 수 있다.In one embodiment, the rutin content of the buckwheat ethanol extract produced by the process of the present invention may be greater than 1000 ppm.
일 측면에서, 본 발명은 본 발명의 방법으로 제조된 메밀싹 에탄올 추출물을 유효성분으로 포함하는 항산화 조성물에 관한 것이다.In one aspect, the present invention relates to an antioxidative composition comprising an extract of buckwheat ethanol produced by the method of the present invention as an active ingredient.
일 측면에서, 본 발명은 본 발명의 방법으로 제조된 메밀싹 에탄올 추출물을 유효성분으로 포함하는 항산화 식품조성물에 관한 것이다.In one aspect, the present invention relates to an antioxidant food composition comprising an extract of buckwheat ethanol produced by the method of the present invention as an active ingredient.
상기 식품 조성물은 분말, 과립, 정제, 캡슐, 시럽 또는 음료의 형태로 제공될 수 있으며, 상기 식품 조성물은 유효성분인 본 발명에 따른 HSF1 억제제 및 BIS 억제제 이외에 다른 식품 또는 식품 첨가물과 함께 사용되고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분의 혼합량은 그의 사용 목적, 예를 들어 예방, 건강 또는 치료적 처치에 따라 적합하게 결정될 수 있다.The food composition may be provided in the form of a powder, granules, tablets, capsules, syrups or beverages. The food composition may be used with food or food additives other than the active ingredient HSF1 inhibitor and BIS inhibitor according to the present invention, Can be suitably used according to the method of The amount of the active ingredient to be mixed can be suitably determined according to the intended use, for example, prevention, health or therapeutic treatment.
상기 건강식품의 종류에는 특별한 제한이 없고, 예로는 육류, 소세지, 빵, 초콜렛, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등을 들 수 있다.There is no particular limitation on the kind of the health food, and examples thereof include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, Drinks, alcoholic beverages and vitamin complexes.
일 측면에서, 본 발명은 본 발명의 방법으로 제조된 메밀싹 에탄올 추출물을 유효성분으로 포함하는 미백 조성물에 관한 것이다.In one aspect, the present invention relates to a whitening composition comprising an extract of buckwheat ethanol produced by the method of the present invention as an active ingredient.
일 측면에서, 본 발명은 본 발명의 방법으로 제조된 메밀싹 에탄올 추출물을 유효성분으로 포함하는 미백 및 항산화용 화장료 조성물에 관한 것이다.In one aspect, the present invention relates to a cosmetic composition for whitening and antioxidation comprising an extract of buckwheat ethanol produced by the method of the present invention as an active ingredient.
본 발명의 화장료 조성물은 상술한 본 발명의 유효성분인 올리고키토산의 화장품학적 유효량(cosmetically effective amount) 및 화장품학적으로 허용되는 담체를 포함하여 제조할 수 있다.The cosmetic composition of the present invention can be prepared by incorporating a cosmetically effective amount of the oligosaccharide as an effective ingredient of the present invention and an cosmetically acceptable carrier.
본 명세서에서 용어 “화장품학적 유효량”은 상술한 본 발명의 조성물의 여드름 유발균에 대한 항균 효능 또는 항염증 효능을 달성하는 데 충분한 양을 의미한다.As used herein, the term " cosmetically effective amount " means an amount sufficient to achieve the antimicrobial or anti-inflammatory efficacy against the acne-causing bacteria of the composition of the present invention described above.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared into any of the formulations conventionally produced in the art and can be used as a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, , Oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it can be manufactured in the form of a soft lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters.
본 발명의 화장료 조성물에 포함되는 성분은 상기 유효 성분 및 담체 성분 이외에, 피부 외용제 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제를 포함할 수 있다.The ingredients contained in the cosmetic composition of the present invention include, in addition to the above-mentioned effective ingredient and carrier component, ingredients conventionally used in the composition for external application for skin, and they can be used in a conventional manner such as an antioxidant, a stabilizer, a solubilizer, a vitamin, May include adjuvants.
하기의 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 그러나 하기 실시예는 본 발명의 내용을 구체화하기 위한 것일 뿐 이에 의해 본 발명이 한정되는 것은 아니다.The present invention will be described in more detail with reference to the following examples. However, the following examples are only for the purpose of illustrating the present invention, and thus the present invention is not limited thereto.
실시예Example . 루틴 함량 최적 발아 조건 수립. Establishment of optimal germination condition
타타리 메밀을 세척한 뒤 동량 부피의 물에 20℃에서 48시간 동안 침지하였다. 그 후, 20℃의 암조건하에서 24시간 동안, 20℃의 광조건하 (LED)에서 8일 동안 발아시켰다. 구체적으로, 광조건은 빛의 세기 2,000, 6,000, 10,000, 14,000, 18,000 및 22,000 Lux로 각각 발아시켰다. 발아된 타타리 메밀을 건조한 뒤 분말화한 뒤, 열수 또는 에탄올을 발아된 타타리메밀 무게의 20배에 달하는 부피로 첨가한 뒤, 초음파 추출기를 이용하여 2.5Hz로 30분간 추출한 뒤, 루틴 함량을 확인하였다 (도 1).The tatami buckwheat was washed and then immersed in the same volume of water at 20 ° C for 48 hours. Thereafter, germination was carried out under a dark condition at 20 DEG C for 24 hours and under a light condition (LED) at 20 DEG C for 8 days. Specifically, light conditions were germinated at light intensity of 2,000, 6,000, 10,000, 14,000, 18,000 and 22,000 Lux, respectively. The germinated tartar buckwheat was dried and powdered. The hot water or ethanol was added in a volume of 20 times the weight of the germinated tartar buckwheat, and then extracted at 2.5 Hz for 30 minutes using an ultrasonic extractor. (Fig. 1).
그 결과, 발아 타타리 메밀 열수 추출물은 빛의 세기에 따라 (10000, 14000, 18000, 22000Lux) 70.24, 79.91, 70.84, 85.47ppm의 함량을 나타내었고, 발아 타타리 메밀 에탄올 추출물은 581.23, 1059.57, 1110.78, 1225.85 ppm의 함량을 나타내어, 에탄올로 추출한 경우 특히 14000Lux에서 루틴의 함량이 현저히 증가하였다 (표 1 및 도 2).As a result, the germinated hot water extract of germinated tartaric acid showed the contents of 70.24, 79.91, 70.84 and 85.47ppm according to the intensity of light (10000, 14000, 18000, 22000 Lux), and the germinated tartaric acid ethanol extract showed 581.23, 1059.57, 1110.78 , And 1225.85 ppm, respectively. In the case of extracting with ethanol, the content of rutin was remarkably increased at 14000 Lux (Table 1 and Fig. 2).
실험예Experimental Example 1. 발아 1. Germination 타타리Tatari 메밀 추출물의 Of buckwheat extract 항산화능Antioxidant ability 확인 Confirm
발아 타타리 메밀 열수 또는 에탄올 추출물의 라디칼 소거능은 ABTS+ decolorization assay 방법을 응용하여 ABTS+(2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 라디칼 소거 활성을 측정함으로써 확인하였다. 구체적으로, ABTS7 mM 및 potassium persulphate 2.5mM을 하루 동안 암소에 방치하고, 이 용액을 734nm에서 흡광도 값이 1.4 내지 1.5가 되도록 증류수로 희석하였다. 희석된 ABTS+ 용액 160㎕에 10%의 농도로 희석된 하기 표 2의 에탄올 및 열수 추출물 40㎕를 가하여 흡광도의 변화를 측정하였다. 표준물질로서 L-Ascorbic acid를 사용하였으며, 활성 저해율이 50%일 때의 시료의 농도(IC50)를 하기 수학식 1을 이용하여 산출하였다. The radical scavenging activity of germinated hydrolyzate or ethanol extracts was determined by measuring the ABTS + (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) radical scavenging activity using ABTS + decolorization assay. Specifically, ABTS7 mM and 2.5 mM potassium persulphate were left in the dark for one day, and the solution was diluted with distilled water to an absorbance value of 1.4 to 1.5 at 734 nm. Dilution to 160 μl of diluted ABTS + Ascorbic acid was used as a standard substance and the concentration (IC 50 ) of the sample when the activity inhibition rate was 50% was calculated by the
a: 공시료액의 반응 후의 흡광도a: Absorbance after reaction of blank sample
b: 시료액의 반응 후의 흡광도b: Absorbance after reaction of the sample solution
b': 완충액으로 대체하여 측정한 흡광도b ': absorbance measured by replacing with buffer
빛(Lux)의 강도에 따른 발아 타타리 메밀 에탄올 또는 열수 추출물의 ABTS+ 라디칼 소거활성을 비교한 결과, 에탄올 추출물은 발아 빛 강도에 따라 루틴 함량이 증가하였으며, 열수 추출물은 14000 lux에서 발아된 타타리 메밀의 루틴 함량이 높은 것으로 나타났다 (표 3 및 도 3). 이를 통해, 에탄올 및 열수 추출물에 포함된 루틴 함량에 의존적으로 ABTS+ 라디칼 소거능이 나타난 것으로 유추할 수 있다. As a result of comparing ABTS + radical scavenging activity of germinated ethanol or hot water extract of germination according to the intensity of light, the ethanol content increased with increasing germination intensity, (Table 3 and Fig. 3). ≪ tb >< TABLE > This suggests that the ABTS + radical scavenging ability is dependent on the rutin content of ethanol and hot water extract.
1ABTS+ 라디칼 소거활성의 양성대조군으로서 IC50 값으로 나타내었다. 1 as a positive control of ABTS + radical scavenging activity was expressed by IC 50 values.
(n=3; **** : P<0.0001 vs non-treated group).(n = 3; ****: P <0.0001 vs non-treated group).
실험예Experimental Example 2. 발아 2. Germination 타타리Tatari 메밀 추출물의 미백 기능 확인 Confirm whitening function of buckwheat extract
발아 타타리 메밀 열수 또는 에탄올 추출물의 티로시나아제 억제 활성을 측정하였다. 구체적으로, 96-웰 플레이트에 0.1 M의 인산염완충액(pH 6.5) 140㎕, 추출물 시료 20㎕ 및 티로시나아제 (1500-2000U/ml) 20㎕를 순서대로 넣고, 이후 1.5 mM의 티로시나아제 20㎕를 추가로 넣은 뒤 37℃에서 20분 동안 반응시켰다. 그 후, 마이크로플레이트 리더기를 이용하여 흡광도를 475nm에서 측정하였다. 음성대조군으로 시료액 (추출물) 대신 0.1M의 인산염완충액 (pH 6.5)를 사용하였으며, 양성대조군으로 Arbutin을 사용하였다. 흡광도 측정치를 이용하여 활성 저해율이 50%일 때의 시료의 농도(IC50)을 산출하였다.The tyrosinase inhibitory activity of the germinated hydrolyzate or ethanol extract of germinated tartaric acid was measured. Specifically, 140 μl of 0.1 M phosphate buffer (pH 6.5), 20 μl of an extract sample, and 20 μl of tyrosinase (1500-2000 U / ml) were sequentially added to a 96-well plate and then 1.5
1Tyrosinase 억제 활성의 양성대조군으로서 IC50 값으로 나타내었다. 1 tyrosinase inhibitory activity as an IC 50 value.
(n=3; **** : P<0.0001, * : <0.05 vs non-treated group).(n = 3; ****: P <0.0001, *: <0.05 vs. non-treated group).
빛(Lux)의 강도에 따른 발아 타타리 메밀 에탄올 또는 열수 추출물의 티로시나아제(Tyrosinase) 억제 활성을 비교한 결과, 루틴함량에 따라 티로시나아제 억제 활성이 증가하였다 (도 4).The tyrosinase inhibitory activity of germination ethanol or hot-water extract of germinated ginseng according to the intensity of light (Lux) was compared with that of tyrosinase inhibitory activity (Fig. 4).
Claims (7)
2) 18 내지 22℃의 암조건하에서 20 내지 30시간 동안 생육하는 단계; 및
3) 14,000Lux 이상의 광조건하에서 8일 동안 생육하여 메밀을 발아시키는 단계를 포함하는, 루틴 함량이 증가된 발아 메밀을 제조하는 방법.1) immersing buckwheat in water;
2) growing under the dark condition of 18 to 22 캜 for 20 to 30 hours; And
3) Growing the buckwheat by growing for 8 days under a light condition of 14,000 Lux or more, thereby producing germinated buckwheat with increased rutin content.
2) 18 내지 22℃의 암조건하에서 20 내지 30시간 동안 생육하는 단계;
3) 14,000Lux 이상의 광조건하에서 8일 동안 생육하여 메밀을 발아시키는 단계;
4) 발아된 메밀을 건조 및 분말화하는 단계; 및
5) 발아 메밀 분말을 에탄올로 추출하는 단계를 포함하는, 루틴 함량이 증가된 메밀싹 에탄올 추출물을 제조하는 방법.1) immersing buckwheat in water;
2) growing under the dark condition of 18 to 22 캜 for 20 to 30 hours;
3) germinating buckwheat grown under light condition of 14,000 Lux or more for 8 days;
4) drying and pulverizing the germinated buckwheat; And
5) Extracting the germinated buckwheat powder with ethanol. A method for producing an ethanol extract of buckwheat sprouts having increased rutin content.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170098288A KR101973860B1 (en) | 2017-08-02 | 2017-08-02 | Method for producing buckwheat sprout with increased rutin contents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170098288A KR101973860B1 (en) | 2017-08-02 | 2017-08-02 | Method for producing buckwheat sprout with increased rutin contents |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190014435A true KR20190014435A (en) | 2019-02-12 |
KR101973860B1 KR101973860B1 (en) | 2019-04-29 |
Family
ID=65369359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170098288A KR101973860B1 (en) | 2017-08-02 | 2017-08-02 | Method for producing buckwheat sprout with increased rutin contents |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101973860B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05163135A (en) * | 1991-12-16 | 1993-06-29 | Suntory Ltd | Beautifying cosmetic composition |
KR20050007463A (en) * | 2002-04-30 | 2005-01-18 | 유승삼 | Method of extracting rutin from buck wheat growed by hydroponics |
KR20110114351A (en) * | 2010-04-13 | 2011-10-19 | 대한민국(관리부서:농촌진흥청장) | Cultivation method of pink-colored tatary buckwehat sprout with high anthocyanin and vitamin c |
KR20160000093A (en) * | 2014-06-23 | 2016-01-04 | 주식회사 코스메카코리아 | A cosmetic composition for antioxidizing and whitening containing the extracts of germinated crops |
-
2017
- 2017-08-02 KR KR1020170098288A patent/KR101973860B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05163135A (en) * | 1991-12-16 | 1993-06-29 | Suntory Ltd | Beautifying cosmetic composition |
KR20050007463A (en) * | 2002-04-30 | 2005-01-18 | 유승삼 | Method of extracting rutin from buck wheat growed by hydroponics |
KR20110114351A (en) * | 2010-04-13 | 2011-10-19 | 대한민국(관리부서:농촌진흥청장) | Cultivation method of pink-colored tatary buckwehat sprout with high anthocyanin and vitamin c |
KR20160000093A (en) * | 2014-06-23 | 2016-01-04 | 주식회사 코스메카코리아 | A cosmetic composition for antioxidizing and whitening containing the extracts of germinated crops |
Non-Patent Citations (1)
Title |
---|
부경대학교 식품공학과 석사학위논문, 신지영 (2016.02.)* * |
Also Published As
Publication number | Publication date |
---|---|
KR101973860B1 (en) | 2019-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101828584B1 (en) | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening | |
WO2019124862A1 (en) | Skin wrinkle prevention and improvement composition containing schisandra chinensis extract as active ingredient | |
KR20170132388A (en) | Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata | |
KR101821024B1 (en) | COMPOSITION OF SKIN WHITENING CONTAINING EXTRACT OF Gloiopeltis Furcata AND METHOD OF MAKING THE SAME | |
KR102476670B1 (en) | Composition for skin improvement comprising multiple extract | |
KR101837020B1 (en) | Separation method for saponins from Sapindus mukorossi and cosmetic composition containing the same | |
KR102425559B1 (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR102612017B1 (en) | Composition for skin improvement comprising multiple extract | |
KR102611916B1 (en) | Composition for skin improvement comprising multiple extract | |
KR101973860B1 (en) | Method for producing buckwheat sprout with increased rutin contents | |
KR101073107B1 (en) | manufacturing method for cosmetics containing berry cocktail composition | |
KR101854766B1 (en) | Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR101525090B1 (en) | Cosmetic Composition for skin Whitening | |
KR102296938B1 (en) | Antioxidant composition comprising veronica longifolia | |
KR102356144B1 (en) | Cosmetic composition and health functional food for skin whitening and anti-wrinkle | |
KR102489463B1 (en) | Composition for whitening comprising extract of microwave treated Dendropanax morbifera | |
KR101551240B1 (en) | Cosmetic Composition for Skin Whitening Having Kaempferia Parviflora | |
KR102313083B1 (en) | An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient | |
KR20220125508A (en) | Composition for antioxidant, anti-inflammation or anti-wrinkle comprising fermented Hibiscus manihot as effective component and manufacturing method thereof | |
KR101276306B1 (en) | Skin whitening composition containing dehydroglyasperin c, dehydroglyasperin d or isoangustone a | |
KR102628373B1 (en) | Composition for skin improvement containing dracorhodin perochlorate | |
KR102644107B1 (en) | Composition for skin improvement containing vomicine | |
KR102636983B1 (en) | Composition for skin improvement containing isodemethylwedelolactone | |
KR20220144652A (en) | Anti-oxidative composition comprising an extract of Machilus thunbergii or a fraction thereof as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |